Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Periodontology|October 17, 1998
Periodontal findings in elderly patients with non-insulin dependent diabetes mellitusH L Collin, M Uusitupa, L Niskanen, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|September 13, 2000
Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathyH L Collin, L Niskanen, M Uusitupa, et al.
European Child & Adolescent Psychiatry|December 20, 2014
Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal studySin T Lo, Elbrich P C Siemensma, Dederieke A M Festen, et al.
Journal of the American Society for Mass Spectrometry|October 2, 2007
Dynamic collision-induced dissociation (DCID) in a quadrupole ion trap using a two-frequency excitation waveform: II. Effects of frequency spacing and scan rateUnige A Laskay, Olivier L Collin, Jennifer J Hyland, et al.
Journal of Periodontal Research|September 27, 2000
Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitusH L Collin, T Sorsa, J H Meurman, et al.
Acta Anaesthesiologica Belgica|January 1, 1984
Preoperative hemodynamic assessment in geriatric patients for elective surgeryY M Bertrand, D Boelens, L Collin, et al.
American Journal on Intellectual and Developmental Disabilities|July 11, 2015
Beneficial Effects of Long-Term Growth Hormone Treatment on Adaptive Functioning in Infants With Prader-Willi SyndromeSin T Lo, Dederieke A M Festen, Roderick F A Tummers-de Lind van Wijngaarden, et al.
British Journal of Pharmacology|October 17, 1998
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activityJ V Selkirk, C Scott, M Ho, et al.
British Journal of Pharmacology|August 28, 1998
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719D R Thomas, S A Gittins, L L Collin, et al.
British Journal of Pharmacology|July 17, 2001
SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissueJ Watson, C Roberts, C Scott, et al.
Pageof 3